Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Extensive preclinical and clinical results presented for Bayer MMP inhibitor

March 30, 1998

Protein farnesyltransferase inhibitors: preclinical studies reported at AACR

March 30, 1998

New hormonal agents discussed at cancer meeting

March 30, 1998

Preclinical and clinical results for liposomal cisplatin presented at AACR meeting

March 30, 1998

Antitumor anthracyclines prepared at Pharmacia & Upjohn

March 27, 1998

Imutec Pharma begins preclinical development of antitumor agents

March 27, 1998

Disappointing preliminary phase III results for lisofylline in BMT

March 27, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...